Correlation Between Edgewise Therapeutics and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Cullinan Oncology LLC, you can compare the effects of market volatilities on Edgewise Therapeutics and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Cullinan Oncology.
Diversification Opportunities for Edgewise Therapeutics and Cullinan Oncology
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Edgewise and Cullinan is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Cullinan Oncology
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 1.18 times more return on investment than Cullinan Oncology. However, Edgewise Therapeutics is 1.18 times more volatile than Cullinan Oncology LLC. It trades about 0.09 of its potential returns per unit of risk. Cullinan Oncology LLC is currently generating about -0.02 per unit of risk. If you would invest 1,633 in Edgewise Therapeutics on August 27, 2024 and sell it today you would earn a total of 1,587 from holding Edgewise Therapeutics or generate 97.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Cullinan Oncology LLC
Performance |
| Timeline |
| Edgewise Therapeutics |
| Cullinan Oncology LLC |
Edgewise Therapeutics and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Cullinan Oncology
The main advantage of trading using opposite Edgewise Therapeutics and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |